Journal Information
Original Article
Full text access
Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?
¿Cuáles son los factores de riesgo para el cambio de bDMARD en el primer año de terapia debido a la falta de eficacia en pacientes con artritis reumatoide?
Ana Martinsa,
, Sofia Pimentaa,b, Daniela Oliveiraa,c, Rafaela Nicolaud, Alexandra Bernardoa, Teresa Martins Rochaa,b, Lúcia Costaa, Miguel Bernardesa,b
a Rheumatology Department, Centro Hospitalar Universitário São João, Porto, Portugal
b Medicine Department, Faculty of Medicine, University of Porto, Porto, Portugal
c Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal
d Rheumatology Department, Centro Hospitalar Tondela-Viseu, Viseu, Portugal

Article

This article is available in English

Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?

Ana Martins, Sofia Pimenta, Daniela Oliveira, Rafaela Nicolau, Alexandra Bernardo, Teresa Martins Rocha, Lúcia Costa, Miguel Bernardes
10.1016/j.reumae.2024.07.008
Reumatol Clin. 2024;20:380-5
Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?